Fundraising Fox
Bolt Biotherapeutics
NASDAQ: BOLTSan Francisco, US · 10 known investors
Find your way into Bolt Biotherapeutics
Sign up to see every warm intro you have to Bolt Biotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bolt Biotherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bolt Biotherapeutics is a clinical-stage biotech company developing novel immunotherapies that leverage innate immune system mechanisms to treat cancer. The company focuses on cancer immunotherapeutics and myeloid biology to address unmet patient needs.
Founders & leadership
Investors · 10
How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us
How we know: Pivotal Life Sciences's portfolio page · the S-1 prospectus · funding news · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: RA Capital's portfolio page · the S-1 prospectus · Not right? Tell us
How we know: Samsara BioCapital's portfolio page · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Vivo Capital's portfolio page · the S-1 prospectus · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: the S-1 prospectus · funding news · press coverage · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
Funding
SEC filings, press & company announcements$51.9M disclosed across 1 of 2 rounds · 2019–2021
- Undisclosed amountSeries BFeb 2019Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
2 people who came through Bolt Biotherapeutics went on to found or lead other companies.
Related companies · 2
Companies working in the same space as Bolt Biotherapeutics.
Frequently asked questions
- What does Bolt Biotherapeutics do?
- Bolt Biotherapeutics is a clinical-stage biotech company developing novel immunotherapies that leverage innate immune system mechanisms to treat cancer. The company focuses on cancer immunotherapeutics and myeloid biology to address unmet patient needs.
- Who founded Bolt Biotherapeutics?
- Bolt Biotherapeutics was founded by Dr. Edgar G. Engleman.
- Who are Bolt Biotherapeutics's investors?
- Bolt Biotherapeutics's investors include Pfizer Venture Investments, Pivotal Life Sciences, RA Capital, Samsara BioCapital, Sofinnova Ventures, Vivo Capital, Nan Fung Life Sciences, Novo Holdings and 2 more.
- How much funding has Bolt Biotherapeutics raised?
- Bolt Biotherapeutics has disclosed $51.9M raised across 1 of its 2 known rounds.
- Where is Bolt Biotherapeutics headquartered?
- Bolt Biotherapeutics is headquartered in San Francisco, US.